Trial Profile
Phase II exploratory study of brostallicin PNU-166196A in patients with ovarian cancer resistant/refractory to platinum based chemotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2011
Price :
$35
*
At a glance
- Drugs Brostallicin (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Nerviano Medical Sciences
- 26 May 2011 New trial record